← Eichor
Study identifier: NCT04873583 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

High Dose Steroids in Children With Stroke

Condition: Paediatric Stroke  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhasePhase 3
Planned participants70
Who can joinAll sexes, 6 Months to 17 Years
Healthy volunteersNo

About this study

This clinical trial deals with focal cerebral arteriopathy and childhood stroke, a rare but devastating condition. Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection and there is increasing evidence that inflammatory processes play a crucial role in childhood stroke, influencing the outcome of the disease. Analysis of existing data suggests that outcomes are improved and that there is less stroke recurrence in children treated with steroids to reduce the acute inflammatory processes. This clinical trial will be conducted in over 20 hospitals in several countries in order to investigate this. Participants will be randomly separated into two groups. The first group will be treated with standard of care (including aspirin) combined with high dose steroids. The second group will be treated with standard of care (including aspirin) but without steroid treatment. The objective is to investigate if children treated with a combination of high dose steroid and aspirin will have a better and quicker recovery of FCA, better clinical functional outcome, and less recurrence compared to children treated with aspirin alone. This project has been identified by international pediatric stroke experts as the most important topic for a clinical trial in the field and is as well one of the most important research priorities identified by parents. The study results will also provide insight into the evolution of inflammatory vessel disease.

This description comes directly from the study's public registry record.

Talk to the study team

Maja Steinlin, Dr. med.  ·  +41 31 6329424  ·  maja.steinlin@insel.ch

Kathrin Bochud, PhD  ·  +41316643472  ·  kathrin.zuercher@insel.ch

Always discuss trial participation with your own doctor first.

Locations (35)

Sydney Childrens Hospital RandwickRandwick, New South Wales, AustraliaRecruiting
Sydney Childrens Hospital NetworkWestmead, New South Wales, AustraliaRecruiting
Melbourne Childrens HospitalMelbourne, Victoria, AustraliaRecruiting
Universitätsklinik für Pädiatrie 1 A.ö. Landeskrankenhaus/ Universitätskliniken InnsbruckInnsbruck, Tyrol, AustriaNot Yet Recruiting
Johannes Kepler University Linz, Med Campus IV, Univ.-Klinik für Kinder- und JugendheilkundeLinz, Upper Austria, AustriaNot Yet Recruiting
Universitätsklinik für Kinder und Jugendheilkunde WienVienna, AustriaRecruiting
Børn og Unge - Aarhus UniversitetshospitalAarhus, DenmarkNot Yet Recruiting
Department of Pediatric and Adolescence Medicine Copenhagen University HospitalCopenhagen, DenmarkRecruiting
L'ASSISTANCE PUBLIQUE-HOPITAUX DE MARSEILLE (AP-HM) - Hôpital de la TimoneMarseille, Aix-en-Provence, FranceRecruiting
Pediatric Neurology Strasbourg - Hautepierre University HospitalStrasbourg, Alsace, FranceRecruiting
Hôpital Femme Mère Enfant LyonBron, Auvergne-Rhône-Alpes, FranceRecruiting
Hôpital Roger Salengro, CHRU de LilleLille, FranceRecruiting

+ 23 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04873583